These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35238017)

  • 1. Medically supervised taper for ultra high-dose opioids with significant comorbidities using a multidisciplinary approach: A case report.
    Wilkes D; Mitchell JM; Winden KJ; Parker D
    J Opioid Manag; 2022; 18(1):85-90. PubMed ID: 35238017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a Proactive Pilot Health Plan-Driven Opioid Tapering Program to Decrease Chronic Opioid Use for Conditions of the Back and Spine in a Medicaid Population.
    Page J; Traver R; Patel S; Saliba C
    J Manag Care Spec Pharm; 2018 Mar; 24(3):191-196. PubMed ID: 29485946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Chronic, Noncancer Pain Management Initiative in a Multidisciplinary Pain Clinic.
    Panicker L; Prasun MA; Stockmann C; Simon J
    Pain Manag Nurs; 2022 Apr; 23(2):122-127. PubMed ID: 34756689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid dose risk, clinician and patient characteristics, and adherence to opioid prescribing recommendations in chronic non-cancer pain.
    Coleman C; Lennon RP; Robinson JM; Tuan WJ; Sehgal N; Zgierska AE
    J Opioid Manag; 2023; 19(5):413-422. PubMed ID: 37968975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose lofexidine for medically directed outpatient opioid tapering in adults with chronic pain: a prospective case series.
    Ellis MM; Eberhart ND; Warner NS; Hooten WM
    J Med Case Rep; 2024 Jan; 18(1):20. PubMed ID: 38229200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Social and Functional Implications of High- Versus Low-Dose Opioids on Chronic Non-Cancer Pain.
    Denawa Y; Kurtz W; Conermann T
    Pain Physician; 2019 Jul; 22(4):401-411. PubMed ID: 31337176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program.
    Cunningham JL; Evans MM; King SM; Gehin JM; Loukianova LL
    Pain Med; 2016 Sep; 17(9):1676-85. PubMed ID: 26755658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine and Cognitive Behavioral Therapy for Rapid Opioid Tapering With Sustained Opioid Abstinence: A Case Report and 1-Year Follow-up.
    Ocker AC; Shah NB; Schwenk ES; Witkowski TA; Cohen MJ; Viscusi ER
    Pain Pract; 2020 Jan; 20(1):95-100. PubMed ID: 31408575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Patients after Opioid Taper in a VA Medical Center.
    Muzzio K; Chandler M; Painter JT; Dragic L
    J Pain Palliat Care Pharmacother; 2021 Jun; 35(2):84-90. PubMed ID: 33956566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapering opioids: a comprehensive qualitative review.
    Davis MP; Digwood G; Mehta Z; McPherson ML
    Ann Palliat Med; 2020 Mar; 9(2):586-610. PubMed ID: 32008341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid tapering in patients with prescription opioid use disorder: A retrospective study.
    Zhou K; Jia P; Bhargava S; Zhang Y; Reza T; Peng YB; Wang GG
    Scand J Pain; 2017 Oct; 17():167-173. PubMed ID: 28988103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.
    Sullivan MD; Turner JA; DiLodovico C; D'Appollonio A; Stephens K; Chan YF
    J Pain; 2017 Mar; 18(3):308-318. PubMed ID: 27908840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex Persistent Opioid Dependence-an Opioid-induced Chronic Pain Syndrome.
    Manhapra A
    Curr Treat Options Oncol; 2022 Jul; 23(7):921-935. PubMed ID: 35435616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System.
    Hundley L; Spradley S; Donelenko S
    J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011.
    Edlund MJ; Austen MA; Sullivan MD; Martin BC; Williams JS; Fortney JC; Hudson TJ
    Pain; 2014 Nov; 155(11):2337-43. PubMed ID: 25180008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid tapering in hematopoietic progenitor cell transplant recipients.
    Pederson C; Parran L
    Oncol Nurs Forum; 2000 Oct; 27(9):1371-80. PubMed ID: 11058969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Acting Opioids Are Associated with Comparable Analgesia to Long-Acting Opioids in Patients with Chronic Osteoarthritis with a Reduced Opioid Equivalence Dosing.
    Ghodke A; Barquero S; Chelminski PR; Ives TJ
    Pain Med; 2018 Nov; 19(11):2191-2195. PubMed ID: 29121327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.
    Kahan M; Mailis-Gagnon A; Wilson L; Srivastava A;
    Can Fam Physician; 2011 Nov; 57(11):1257-66, e407-18. PubMed ID: 22084455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.